Ticagrelor in patients with acute coronary syndrome without ST elevation and a conservative treatment strategy

Ticagrelor in patients with acute coronary syndrome without ST elevation and a conservative treatment strategy

The article provides an overview of the relevance of the use of dual antiplatelet therapy (DAT) in patients with acute coronary syndrome (ACS) without lifting ST (ACSwl ST ) receiving conservative treatment. Compared with those patients with ACSwl ST who underwent percutaneous coronary intervention,...

Full description

Bibliographic Details
Main Author:	A. D Erlikh
Format:	Article
Language:	English
Published:	Concilium Medicum 2016-03-01
Series:	КардиоСоматика
Subjects:	acute coronary syndrome ticagrelor conservative strategy outcomes
Online Access:	https://cardiosomatics.orscience.ru/2221-7185/article/view/45194

Similar Items

Analysis of ticagrelor’s cardio-protective effects on patients with ST-segment elevation acute coronary syndrome accompanied with diabetes
by: Li Dong-Tao, et al.
Published: (2019-02-01)

Results of clinical studies PLATO and place of ticagrelor in the treatment of acute coronary syndrome
by: A. D Erlih
Published: (2015-03-01)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
by: Dong Wang, et al.
Published: (2018-11-01)

Ticagrelor hemorrhagic safety in patients with acute coronary syndrome with ST-segment elevation received thrombolytic therapy in daily clinical practice: 30-day observation results
by: A. V. Bocharov, et al.
Published: (2020-05-01)

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in Chinese elderly patients with acute coronary syndrome
by: Wang HD, et al.
Published: (2016-07-01)

Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome
by: Liu, H., et al.
Published: (2022)

Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis
by: Mingxiang Wen, et al.
Published: (2020-10-01)

Long-term cost-effectiveness of ticagrelor versus clopidogrel in acute coronary syndrome in Spain
by: E. Molina-Cuadrado, et al.
Published: (2014-07-01)

Efficacy and safety of ticagrelor versus clopidogrel with different dosages in acute coronary syndrome patients with high GRACE and CRUSADE scores
by: Peng Xiao, et al.
Published: (2021-05-01)

Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials
by: Pravesh Kumar Bundhun, et al.
Published: (2017-12-01)

Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial
by: Cai-De Jin, et al.
Published: (2021-06-01)

Characteristics and outcomes in patients with atrial fibrillation and acute coronary syndrome treated with ticagrelor and novel oral anticoagulants
by: Jesper van der Pals, et al.
Published: (2021-05-01)

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
by: Fan ZG, et al.
Published: (2019-02-01)

Rational and Design of ST-ON-SET: Assessment of Antiplatelet effect after Ticagrelor Loading Dose in STEMI Patients and NSTEMI Patients
by: Hongyi Wu, et al.
Published: (2016-01-01)

A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome
by: Nafrialdi Nafrialdi, et al.
Published: (2018-12-01)

Cost analysis of dual antiplatelet therapy with prasugrel and ticagrelor in patients with acute coronary syndrome after percutaneous coronary intervention
by: I. N. Dyakov, et al.
Published: (2020-09-01)

Comparison of Efficacy between Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome after Interventional Treatment and Their Effects on IL-6
by: Bin YANG, et al.
Published: (2020-02-01)

Budget impact analysis of antiplatelet therapy with ticagrelor and clopidogrel in patients with acute coronary syndrome after coronary artery bypass surgery
by: S K Zyryanov, et al.
Published: (2016-09-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Effect of discontinuation of ticagrelor and switching-over to other P2Y12 agents in patients with acute coronary syndrome: a single-center real-world experience from India
by: Nagendra Boopathy Senguttuvan, et al.
Published: (2021-01-01)

P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Po-Wei Chen, et al.
Published: (2020-06-01)

Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis
by: Matteo Vercellino, et al.
Published: (2017-04-01)

A meta-analysis of the safety of clopidogrel and tegrarol in patients with non-ST elevation acute coronary syndrome after PCI in China
by: Xiao-Min Gao, et al.
Published: (2020-08-01)

Temporal Trends of Bleeding Episodes during Half- vs. Standard-Dose Ticagrelor in Acute Coronary Syndrome Patients with Low Platelet Reactivity: A Randomized BLEEDING-ACS Trial
by: Laeun Kim, et al.
Published: (2021-03-01)

A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS
by: O. L. Barbarash, et al.
Published: (2017-12-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Clopidogrel or ticagrelor alongside dabigatran in acute coronary syndrome and indication for NOAC: A study rationale
by: Luijkx, J., et al.
Published: (2022)

Acute and spontaneous coronary thrombosis in non-culprit artery during percutaneous coronary intervention in myocardial infarction with ST-segment elevation: A “shocking” case
by: Dario Buccheri, et al.
Published: (2015-12-01)

Platelet Inhibition, Revascularization, and Risk Prediction in Non-ST-elevation Acute Coronary Syndromes
by: Lindholm, Daniel
Published: (2015)

Comparison of ESC and ACCF/AHA Guidelines for Oral Antiplatelet Treatment in the Management of Patients with Acute Coronary Syndrome
by: Ayhan Sarıtaş, et al.
Published: (2016-09-01)

The choice of the P2Y12 receptors blocker in the treatment of a patient with acute coronary syndrome: practice of N.I. Pirogov city clinical hospital №1
by: M. R. Atabegashvili, et al.
Published: (2019-04-01)

Spontaneous subdural hematoma and antiplatelet therapy: Does efficacy of Ticagrelor come with added risk?
by: Pattanagere Manjunatha Suryanarayana Sharma, et al.
Published: (2015-12-01)

Myocardium-protective effect of ticagrelor combined with emergency PCI treatment of acute myocardial infarction
by: Yu-Jun Zhao
Published: (2016-09-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes
by: Sammer Diab, et al.
Published: (2021-05-01)

Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding
by: Paolo Nardi, et al.
Published: (2020-01-01)

Acute coronary syndrome without ST elevation (NSTEMI)
by: Niković Vuk, et al.
Published: (2016-01-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Ticagrelor – toward more efficient platelet inhibition and beyond
by: Kubisa MJ, et al.
Published: (2018-01-01)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
by: Aguiar, M.O, et al.
Published: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldrp8no43ceadqkbq5juobbpuf